Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº?
³»   ¿ë

ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº?

´ëÇѾà»çȸ »çÀ̹ö¿¬¼ö¿ø°ú ¿Â¶óÀÎ ¿¬¼ö±³À°ÀÇ ¹Ì·¡¸¦ ޱ¸ÇÏ´Ù <4>


´ëÇѾà»çȸ´Â ¾à»ç¿¬¼ö±³À°À» °³ÆíÇÏ¿© 2020³â »çÀ̹ö¿¬¼ö¿øÀ» ±¸ÃàÇß´Ù. »çÀ̹ö¿¬¼ö¿øÀ» ÅëÇÑ ¿Â¶óÀΠ¿¬¼ö±³À°ÀÇ ½ÃÇà°ú ÇÔ²² ¿¬¼ö¿øÀÇ È¿À²ÀûÀΠ¿î¿µ ¹æÇâ°ú ¾à»çµé¿¡°Ô ¾çÁúÀÇ ±³À°À» Á¦°øÇϱâ À§ÇÑ ¿Â¶óÀΠ¿¬¼ö±³À°¼¾ÅÍÀÇ ¹ßÀü ¹æÇâ Á¦¾ÈÀÌ ¿ä±¸µÇ°í ÀÖ´Ù. ¸¹Àº ¼±Áø±¹Àº ¾à»ç¿¬¼ö±³À°¿¡ CPD(Continuing Professional Development) °³³äÀ» Àû¿ëÇϰí ÀÖ´Ù. CPD´Â Á¦2Â÷ ¼¼°è´ëÀü ´ç½Ã¿¡ Àü¹®°¡µé¿¡ ´ëÇÏ¿© Áö¼ÓÀû ¹× Ã¼°èÀûÀΠ°³¹ßÀ» ÇÒ ÇÊ¿ä·Î Ã³À½ µîÀåÇß´Ù. ÀÌÈÄ º»°ÝÀûÀ¸·Î CPD ÀÎÁõ ¼­ºñ½º°¡ Ã³À½ Àû¿ëµÈ °ÍÀº 1996³â ¿µ±¹ °Ç¼³¾÷ ºÐ¾ß¿´°í, ¼¼°è¾à»ç¿¬¸Í(International Pharmaceutical Federation, FIP)´Â 2002³â CPD¸¦ Àå·ÁÇϱâ À§ÇÑ ¼º¸í¼­¸¦ ¹ßÇ¥Çß´Ù. 2020³â »çÀ̹ö¿¬¼ö¿øÀÇ ¿ÀÇÂÀº ¾à»ç¿¬¼ö±³À°¿¡ Å« ¹ßµ¸¿òÀ̾ú´Ù. Äڷγª ½Ã±â¿Í ¸Â¹°·Á Áýü±³À°ÀÌ ¾î·Á¿öÁø »óȲ¿¡¼­ ¿Â¶óÀΠ¿¬¼ö±³À°Àº ´õ¿í ºûÀ» ¹ßÇϰí Àֱ⵵ ÇÏ´Ù. ±×·¯³ª ±¹Á¦ ¾à»ç »çȸ¿¡¼­ CPD°¡ µµÀԵȠÁö ¾à 20³âÀÌ Áö³­ Áö±Ý±îÁö ±¹³» ¿¬¼ö±³À°¿¡¼­ CPDÀÇ °³³äÀº Ã£¾Æº¼ ¼ö ¾ø´Ù. ±¹Á¦Àû ±âÁØ¿¡ »óÀÀÇϴ ±¹Á¦ ¼öÁØÀÇ ¾à»ç Àη ¾ç¼ºÀ» À§ÇØ ¾àÇдëÇÐÀÌ 6³âÁ¦·Î °³ÆíµÇ¾úÁö¸¸, Á¹¾÷ ÀÌÈÄ Áö¼ÓÇØ¼­ °æÀï·Â Àִ ¾à»ç ÀÎÀ縦 °³¹ßÇϱâ À§ÇÑ ±â¹ÝÀº ¾ÆÁ÷ ¸¶·ÃµÇ¾î ÀÖÁö ¾Ê´Ù. ÀÌ¿¡ µû¶ó, º» °í¿¡¼­´Â CPD Àû¿ëÀ» À§ÇØ ±¹³» ¿¬¼ö±³À°¿¡ ÇÊ¿äÇÑ ¿ä¼ÒµéÀ» Áß½ÉÀ¸·Î ±¹³» ¿Â¶óÀΠ¿¬¼ö±³À°ÀÇ ¹Ì·¡ ¹ßÀü ¹æÇâÀ» Å½±¸Çغ¸°íÀÚ ÇÑ´Ù.


¾çÁúÀÇ ¿¬¼ö±³À°À» À§ÇÑ Æò°¡
¿©±â¼­ À̾߱âÇϴ Æò°¡´Â ¿¬¼ö±³À° ÀÚüÀÇ ÁúÀ» Æò°¡Çϴ °ÍÀ¸·Î ¾Õ¼­ ¼ö°­ÀÚÀÇ Á¦´ë·Î µÈ ÇнÀ ¿©ºÎ¸¦ Æò°¡Çϴ °Í°ú´Â ´Ù¸¥ °³³äÀÌ´Ù. 

¿¬¼ö±³À°ÀÇ ÁúÀ» À¯ÁöÇϱâ À§Çؼ­´Â Ã¼°èÀûÀΠÆò°¡°¡ ÀÌ·ç¾îÁ®¾ß ÇÒ Çʿ䰡 ÀÖ´Ù. 

Ŀũ ÆÐÆ®¸¯ÀÇ ¸ðµ¨<±×¸²7>Àº ±³À° ¶Ç´Â ÈƷàÇÁ·Î±×·¥À» Æò°¡Çϱâ À§ÇØ °¡Àå ÈçÇϰԠ»ç¿ëµÇ´Â ¸ðµ¨ÀÌ´Ù. 


ÀÌ ¸ðµ¨Àº ¡®¹ÝÀÀ¡¯, ¡®ÇнÀ¡¯, ¡®Çൿ¡¯, ±×¸®°í ¡®°á°ú¡¯ 4´Ü°è¿¡ µû¶ó ±³À°ÀÇ È¿°ú¸¦ Æò°¡ÇÑ´Ù. 

°¢ ´Ü°è¿¡ ´ëÇÑ °£´ÜÇÑ ¼³¸íÀº <Ç¥3>¿Í °°´Ù.


±¹³»¿¡¼­ ÇöÀç ¾à»ç¿¬¼ö±³À°ÀÇ Æò°¡¸¦ À§ÇØ »ç¿ëÁßÀΠÆò°¡ ¹®Ç×Àº ´ëºÎºÐ ¡®¹ÝÀÀ¡¯ ¿µ¿ªÀÇ Àü¹ÝÀûÀΠ°­ÀÇ ¸¸Á·µµ¸¦ Æò°¡Çϴ µ¥ ÁýÁßµÅÀÖ´Ù. 

Á¦´ë·Î µÈ Æò°¡¸¦ À§Çؼ­´Â ´Ù¸¥ ¿µ¿ªµé°ú ÇÔ²² ¹ÝÀÀ¿µ¿ª ³»¿¡¼­ ÇнÀ µ¿±â, ±³À° ¸Å°³Ã¼µé¿¡ ´ëÇÑ Æò°¡¸¦ ¼öÇàÇϴ °ÍÀÌ ÇÊ¿äÇÏ´Ù. 

´Ü ¹®Ç×ÀÌ °úµµÇϰԠ¸¹¾ÆÁö¸é ¼ö°­ÀÚÀÇ Æò°¡ ÀÇÁö°¡ ÀúÇϵɠ°ÍÀ» °í·ÁÇØ ÀûÀýÇÑ ¼öÀÇ Æò°¡ ¹®Ç× °³¹ßÀÌ ÇÊ¿äÇÏ´Ù. 

º» ¿¬±¸¼Ò¿¡¼­´Â ¿ÃÇØ ¡®¾à»ç¿¬¼ö±³À°ÀÇ ¿Â¶óÀμ¾Å͠Ȱ¿ë ¹× Æò°¡¹æ¾È ¿¬±¸¡¯¸¦ ¼öÇàÇØ ¿¬¼ö±³À°ÀÇ Æò°¡¿¡ È°¿ëµÉ ¼ö Àִ Æò°¡¸ðµ¨°ú ¹®Ç×µéÀ» °³¹ßÇß´Ù. 

À̴ Â÷ÈÄ ¿¬±¸¼Ò È¨ÆäÀÌÁö¿¡¼­ È®ÀÎÇÒ ¼ö ÀÖ´Ù. 

³ª°¡¸ç
¾Õ¼­ ¸»ÇßµíÀÌ »çÀ̹ö¿¬¼ö¿øÀÇ °³¼³Àº ¾à»ç ¿¬¼ö±³À°¿¡ Å« ¹ßÀüÀÌ´Ù. 

±¹¿Ü»Ó¸¸ ¾Æ´Ï¶ó ±¹³»¿¡¼­µµ ´Ù¸¥ Á÷´Éµé¿¡ ºñÇØ °³¼³ÀÌ ´Ê¾îÁö±ä ÇßÁö¸¸, ÀÌÁ¦¶óµµ ÇöÀå¿¡¼­ ¹Ù»Ú°Ô ÀÏÇϴ ¾à»çµéÀÌ ½Ã°£°ú °ø°£¿¡ Á¦¾à¹ÞÁö ¾Ê°í ¿¬¼ö±³À°À» ¼ö°­ÇÒ ¼ö ÀÖ°Ô µÈ °ÍÀÌ´Ù. 

¼ö°­ÀÚ°¡ °­»ç¿Í Á÷Á¢ÀûÀ¸·Î ¼ÒÅëÇÒ ¼ö ¾ø°í ÀÛÀº È­¸éÀ» ÅëÇØ ÀϹæÀûÀ¸·Î Á¤º¸¸¦ Àü´Þ¹Þ´Â ¿Â¶óÀΠ±³À°Àº ÇöÀå ±³À°º¸´Ù ¸øÇϴٴ Àǰߠ¶ÇÇÑ Á¸ÀçÇÑ´Ù. 

±×·¯³ª ¿Â¶óÀΠ±³À°°ú ÇöÀå ±³À°Àº µÑ Áß ¾î´À Çϳª°¡ Æ²·È´Ù´Â Ç¥Çöº¸´Ù´Â ´Ù¸£´Ù´Â Ç¥ÇöÀÌ ÀûÇÕÇÏ´Ù ÇÒ °ÍÀÌ´Ù. 

¿Â¶óÀΠ±³À°Àº ´ÜÁ¡µµ ÀÖÁö¸¸, ½Ã°ø°£¿¡ Á¦¾àÀÌ ¾ø°í ¿©·¯ µðÁöÅР±â¼úµéÀ» È°¿ëÇÒ ¼ö Àִٴ ºÐ¸íÇÑ ÀåÁ¡µµ Á¸ÀçÇÑ´Ù. 

¾î´À ÇüÅÂÀÇ ±³À°À» ¼±ÅÃÇÒÁö´Â º»ÀÎÀÇ ¿ä±¸µµ¸¦ °¡Àå Àß ÆÄ¾ÇÇϰí Àִ ¼ö°­ÀÚ¿¡°Ô ´Þ·ÁÀÖ´Ù. 

´Ü ¿Â¶óÀΠ±³À°ÀÇ ´ÜÁ¡À» ±Øº¹Çϱâ À§Çؼ­´Â ¿©·¯ Á¢±ÙÀÌ ÇÊ¿äÇÏ´Ù. 

µðÁöÅР±â¼úÀ» È°¿ëÇØ ¾Õ¼­ Á¦½ÃÇÑ ¹æ½ÄÀ» ¹Ý¿µÇÑ Continuing Professional Development¸¦ »çÀ̹ö¿¬¼ö¿ø¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Ù¸é, ¿Â¶óÀΠ¿¬¼ö±³À°ÀÇ ÀåÁ¡À» º¸´Ù ´õ ±Ø´ëÈ­ÇÒ ¼ö ÀÖÀ» °ÍÀÌ´Ù.


[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=447

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
99 [´ëÇѾà»çÀú³Î] ó¹æ ÀûÁ¤¼º '°³¼±' ÀÌ»ó¹ÝÀÀ ¹ß»ý·ü '°¨¼Ò' ÀÌÁö¿¬ 2021-02-23 486
98 [´ëÇѾà»çÀú³Î] ÇØ¿Ü 85% º´¿ø, Ç×»ýÁ¦ »ç¿ë ¸ð´ÏÅ͸µ ½Ç½Ã ÀÌÁö¿¬ 2021-02-16 464
97 [´ëÇѾà»çÀú³Î] °¨¿°Àü¹®¾à»ç ÇÁ·Î±×·¥ ¼±µÎ¡¦ÀÇ·áÁø°ú ÆÀÀÇ·á ÀÌÁö¿¬ 2021-02-10 453
96 [¾à»ç°ø·Ð]´ÙÁ¦¾à¹° ÃÊÁ¡, 'Çѱ¹Çü Åð¿øÄɾºñ½º' ±¹Á¦¹«´ë¼­ 'ÁÖ¸ñ' ±è¼±Èñ 2021-02-04 505
95 [¸Þµð°ÔÀÌÆ®]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, FIP¿¡ Çѱ¹ Åð¿øÄɾºñ½º ¼Ò°³ ±è¼±Èñ 2021-02-04 536
94 [´ëÇѾà»çÀú³Î] Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ÇöȲ ¹× ¿î¿µ ¹æ¾È ÀÌÁö¿¬ 2021-02-02 499
93 [´ëÇѾà»çÀú³Î] ȯÀÚ 'Æ÷°ýÀû ¾à¹° »ç¿ë °ü¸®' ÁÖ¿ä °ú¾÷ ÀÌÁö¿¬ 2021-01-26 487
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£ ±è¼±Èñ 2021-01-19 556
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå' ±è¼±Èñ 2021-01-19 527
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö' ±è¼±Èñ 2021-01-19 491
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡ ÀÌÁö¿¬ 2021-01-19 401
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 480
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 513
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 494
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 497

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»